Small-Cell Lung Cancer

This page contains recent news articles, when available, and an overview of Small-Cell Lung Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Small-Cell Lung Cancer

Opiate Painkillers May Encourage Spread Of Cancer  -  23 Nov 2009
Medical News TodayThey used two different models of of non-small cell lung cancer and showed that MNTX inhibited the tumor-promoting effects of opiates. ...

Anatomic segmentectomy for stage I non–small-cell lung cancer: Comparison of ...  -  23 Nov 2009
The Journal of Thoracic and Cardiovascular SurgeryMethods: A total of 225 consecutive anatomic segmentectomies were performed for stage IA (n = 138) or IB (n = 87) non–small-cell lung cancer from 2002 to ...

Poniard Announces $7.4 Million Financing  -  23 Nov 2009
PR Newswire (press release)Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in the second-line treatment of patients with small cell lung cancer. ...

Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study ...  -  23 Nov 2009
Earthtimes (press release)The ADVANCE (Assessment of Docetaxel and Vascular Disruption in Non-Small Cell Lung Cancer) trial is investigating plinabulin in combination with docetaxel ...

Avastin not recommended for treatment of GBM  -  23 Nov 2009
Pharmacy Europe...treatment of the advanced stages of four common types of cancer: colorecta cancer, breast cancer, non-small cell lung cancer NSCLC) and kideney cancer. ...

Poniard Shares Tumble As Lung Cancer Drug Doesn't Meet Goal  -  ‎Nov 16, 2009‎
Wall Street JournalPoniard Pharmaceuticals Inc.'s (PARD) picoplatin treatment for small-cell lung cancer didn't meet its primary overall survival endpoint in a late-stage ...

OXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non ...  -  ‎Nov 17, 2009‎
CNNMoney.com (press release)A Phase II study in platinum-resistant ovarian cancer has been completed and a non-small cell lung cancer study combining fosbretabulin with bevacizumab and ...

Concurrent Radiotherapy, Chemotherapy Shows Promise In Small Cell Lung Cancer  -  ‎Nov 3, 2009‎
Science Daily (press release)4, 2009) — Treating limited stage small cell lung cancer (LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown ...

Basilea presents new research data on oncology drug candidate BAL27862 at ...  -  ‎Nov 18, 2009‎
CNNMoney.com (press release)...on Molecular Targets and Cancer Therapeutics reveal that BAL27862 has impressive activity against a panel of non small cell lung cancer cell lines, ...

Rodent of the Week: Drug shows effect on lung cancer tumors  -  ‎Nov 13, 2009‎
Los Angeles TimesSmall-cell lung cancer is a disease sorely in need of better therapies. Now a study in mice has found a promising drug that may enter clinical trials in ...

ASCO Releases Updated Treatment Guidelines for Patients with Stage 4 Non-Small ...  -  ‎Nov 22, 2009‎
Media Newswire (press release)New recommendations on the use of chemotherapy to treat patients with stage 4 non-small cell lung cancer (NSCLC) were issued today by the American Society ...

EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix  -  ‎Nov 20, 2009‎
CNNMoney.com...a generic of Taxotere, which is authorized in the European Union for the treatment of breast cancer, non-small-cell lung cancer, prostate cancer, ...

New drug for small cell lung cancer?  -  ‎Nov 10, 2009‎
Examiner.comSmall cell lung cancer forms about 15-20% of the total cases of lung cancer. It is the most aggressive form of cancer that occurs within the lungs and grows ...

Merck Serono: CHMP Opinion for Erbitux in Advanced Non-Small Cell Lung Cancer  -  ‎Nov 20, 2009‎
PharmiWeb.com (press release)For more information on Erbitux in colorectal, head & neck and non-small cell lung cancer, please visit: www.globalcancernews.com.

What's New in...Lung Cancer  -  ‎Nov 16, 2009‎
American Journal of Hemotology and OncologySurgical resection is the optimal treatment for stage I non–small cell lung cancer (NSCLC), and imaging tests are a key factor in determining whether a ...

Locals aid Hill family  -  ‎Nov 21, 2009‎
Marshall News MessengerHill, a Marshall native, is undergoing chemotherapy treatments after being diagnosed with small cell lung cancer in September. Paul Hill, center, talks with ...

ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound ...  -  ‎Nov 17, 2009‎
WELT ONLINEIMGN901 is a potential treatment for MCC, small-cell lung cancer, multiple myeloma, ovarian cancers and other CD56+ tumors. It is in Phase I testing for the ...

Abraxis BioScience Reports 2009 Third Quarter Financial Results  -  ‎Nov 5, 2009‎
ReutersThe majority of the increase was due to additional spending on Phase III clinical trials for non-small cell lung cancer, pancreatic cancer and melanoma. ...

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special ...  -  ‎Nov 4, 2009‎
ReutersLucanix® consists of four non-small cell lung cancer cell lines that have been gene-modified to block a molecule called transforming growth factor-beta ...

It's Round 2 in veteran Jacksonville reporter's cancer battle  -  ‎Nov 18, 2009‎
Florida Times-UnionRound two of my chemical battle against small-cell lung cancer begins Thursday morning. Every Thursday except for Thanksgiving, ...

Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 ...  -  ‎Nov 18, 2009‎
WELT ONLINETumor types include non-small cell lung cancer (NSCLC) (8), colorectal cancer (5), hepatocellular carcinoma, head and neck squamous cell carcinoma, ...

Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at ...  -  ‎Nov 19, 2009‎
CNNMoney.com (press release)The authors concluded that RNAi phenotype profiling of non-small cell lung cancer cells identified significant pathways that suggest synergistic ...

New Treatment Option Emerging For Some With Early Stage Lung Cancer  -  ‎Nov 3, 2009‎
Science Daily (press release)3, 2009) — Patients with early stage, non-small cell lung cancer who are not able to undergo surgery, now have a highly effective treatment option. ...

Study resets the risk, benefits of preventive radiation  -  ‎Nov 12, 2009‎
Cancerfacts.com11, 2009 – A new study taking a closer look at the risks and benefits of brain radiation therapy to prevent non-small cell lung cancer from spreading to the ...

ANALYSIS-Cancer trial results could make Poniard M&A target  -  ‎Nov 13, 2009‎
ForbesPoniard, whose data on the late-stage trial for small cell lung cancer is expected in November, is looking for a partner to help market the lung cancer drug ...

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090  -  ‎Nov 18, 2009‎
RTT News (press release)In vivo studies of STA-9090 demonstrated strong single agent activity in cancers such as non-small cell lung cancer, gastric carcinoma and melanoma and ...

Cancer hits Tennesseans hard  -  ‎Nov 15, 2009‎
The TennesseanHe didn't quit until a few weeks after that, when a Vanderbilt-Ingram Cancer Center doctor who diagnosed his small-cell lung cancer said, "You know the ...

Novelos Therapeutics and Academic Collaborators Present Scientific Findings at ...  -  ‎Nov 16, 2009‎
WELT ONLINENOV-002 is in a pivotal Phase 3 trial for non-small cell lung cancer under a Special Protocol Assessment (SPA) and Fast Track, which is expected to conclude ...

New Markers of Prognosis for Cancer Therapies Highlighted  -  ‎Nov 18, 2009‎
PhysOrg.comScreening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to ...

Corporate Watch  -  ‎Oct 28, 2009‎
Wall Street JournalAgency to use the drug in combination with chemotherapy to treat advanced, non-small-cell lung cancer in patients who had tried other cancer therapies. ...

PET Imaging Response A Prognostic Factor After Thoracic Radiation Therapy For ...  -  ‎Nov 7, 2009‎
Science Daily (press release)6, 2009) — A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor ...

Intervals Between Lung Cancer Diagnosis And Treatment Displays A Health Care ...  -  ‎Nov 1, 2009‎
Science Daily (press release)...and his team of researchers conducted a retrospective analysis of 482 patients diagnosed with non-small cell lung cancer among a diverse population. ...

Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall ...  -  ‎Oct 30, 2009‎
Reuters...the efficacy and safety not only in breast cancer, but also in non-small cell lung cancer (NSCLC), hormone refractory prostate cancer, and sarcoma. ...

Antisoma AGM update and Interim Management Statement  -  ‎Nov 9, 2009‎
CNNMoney.com (press release)This 1200-patient study is evaluating ASA404 in combination with standard chemotherapy as a first-line treatment for non-small cell lung cancer. ...

Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 ...  -  ‎Nov 17, 2009‎
WELT ONLINE...will be dose-escalated up to 225 mg/m 2 and AUC 6, respectively, with expansion at the MTD in patients with non-small cell lung cancer (NSCLC). ...

Experimental drug may treat lung cancer  -  ‎Nov 15, 2009‎
PRESS TVSmall cell lung cancer tumors, a form of lung tumor with low survival rate, cannot be treated with surgery as they spread so fast in the body. ...

Age should not affect chemotherapy choice for stage IV lung cancer: guidelines  -  ‎Nov 17, 2009‎
Curetoday.com (press release)NEW YORK (Reuters Health) - In an update to its 2003 guidelines for stage IV non-small-cell lung cancer (NSCLC) chemotherapy, the American Society of ...

ODAC will Review Tarceva for Maintenance Therapy in Advanced Non-Small Cell ...  -  ‎Nov 17, 2009‎
Trading Markets (press release)...non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum-based chemotherapy at its December 16, meeting. ...

Market Report -- In Play (OSIP)  -  ‎Nov 16, 2009‎
MSN Money...reviewed by the FDA's Oncologic Drugs Advisory Committee for use as a first-line maintenance therapy in advanced non-small cell lung cancer Co announces ...

OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings  -  ‎Nov 12, 2009‎
CNNMoney.com (press release)Phase 2 study of ZYBRESTAT(TM) in combination with Avastin(R) (bevacizumab) and chemotherapy in patients with advanced non-small cell lung cancer at a ...

CHMP turns Erbitux down again for metastatic NSCLC  -  ‎Nov 20, 2009‎
Pharma Times...with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor-expressing metastatic non-small cell lung cancer. ...

European medical advisory committee does not recommend approval of Avastin for ...  -  ‎Nov 21, 2009‎
PipelineReview.com (press release)...treatment of the advanced stages of four common types of cancer: colorectal cancer, breast cancer, non-small cell lung cancer (NSCLC) and kidney cancer. ...

No Reduction in Transfusions with ESAs  -  ‎Nov 10, 2009‎
MedPage TodayThey identified 56210 patients who were diagnosed with diffuse large B-cell lymphoma, breast cancer, non-small cell lung cancer, or colon cancer over a ...

BUSINESS WIRE: Erbitux Recognized by ASCO as a 2009 Major Cancer Advance as ...  -  ‎Nov 16, 2009‎
Vereinigte WirtschaftsdiensteFor more information on Erbitux in colorectal, head & neck and non-small cell lung cancer, please visit: www.globalcancernews.com. ...

Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and ...  -  ‎Nov 5, 2009‎
Reuters..."We are pleased to have presented clinical data of IMO-2055 in renal cell cancer and in non-small cell lung cancer. We look forward to presenting data from ...

Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at ...  -  ‎Oct 30, 2009‎
Reuters...positive breast cancer, neck cancer, T-cell and natural-killer-cell neoplasms, advanced non-small-cell lung cancer, liver cancer and endometrial cancer. ...

ImmunoGen Announces IMGN901 Data (NASDAQ:IMGN)  -  ‎Nov 18, 2009‎
FavStocks (blog)In other words, IMGN901 is a potential treatment for MCC, small-cell lung cancer, multiple myeloma, ovarian cancers and other CD56+ tumors. ...

Stereotactic body radiation therapy stopped cancer growth in inoperable early ...  -  ‎Nov 9, 2009‎
HemOncTodayIn frail patients with inoperable non–small cell lung cancer, treatment with stereotactic body radiation therapy resulted in a high rate of local tumor ...

Moffitt wins $19 million in stimulus grants  -  ‎Nov 19, 2009‎
Tampa Bay Business Journal...$2.1 million to Srikumar Chellappan to examine the role of the human gene ID1 in the progression of non-small-cell lung cancer. ...

Poniard Pharmaceuticals to Present Updated Clinical Data from Phase 2 Trial of ...  -  ‎Nov 10, 2009‎
CNNMoney.com (press release)Phase 3 SPEAR trial in patients with small cell lung cancer, and in a Phase 2 clinical trial in patients with castration-resistant prostate cancer. ...



Background information on Small-Cell Lung Cancer [When available]

Lung cancer is a malignant tumour of the lungs. Most commonly it is bronchogenic carcinoma (about 90%). Lung cancer is the most lethal malignant tumour worldwide, causing up to 3 million deaths annually.

The most important risk factor for lung cancer is smoking.

Treatment and prognosis depend upon the histological type of cancer and the stage (degree of spread). Possible treatment modalities include surgery, chemotherapy) and/or radiotherapy.

Search the web for more resources on Small-Cell Lung Cancer



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy